✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

SMS Lifesciences India Ltd.

SMSLIFE

Market Cap
₹380 Cr.
P/E
16.48

SMS Lifesciences India Ltd.

  • SMS Lifesciences
  • Everest Organics
  • Nectar Lifesciences
  • TJI Pharma - Small Cap
FAQs on SMS Lifesciences India Ltd. Shareprice

SMS Lifesciences has given better returns compared to its competitors.
SMS Lifesciences has grown at ~17.15% over the last 7yrs while peers have grown at a median rate of 2.02%

SMS Lifesciences is not expensive.
Latest PE of SMS Lifesciences is 16.48, while 3 year average PE is 18.15.
Also latest EV/EBITDA of SMS Lifesciences is 9.56 while 3yr average is 9.75.

View FAQ's On Business
Growth Table
  • SMS Lifesciences India Ltd.
  • Everest Organics
  • Nectar Lifesciences
Balance Sheet
  • SMS Lifesciences India Ltd.
  • Everest Organics
  • Nectar Lifesciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • SMS Lifesciences India Ltd.
  • Everest Organics
  • Nectar Lifesciences
Cash Flow
  • SMS Lifesciences India Ltd.
  • Everest Organics
  • Nectar Lifesciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • SMS Lifesciences India Ltd.
  • Everest Organics
  • Nectar Lifesciences
Quarterly Results
  • SMS Lifesciences India Ltd.
  • Everest Organics
  • Nectar Lifesciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on SMS Lifesciences India Ltd. Financials

Balance sheet of SMS Lifesciences is moderately strong, But short term working capital might become an issue for this company.

The net debt of SMS Lifesciences is decreasing.
Latest net debt of SMS Lifesciences is ₹88.3 Crs as of Sep-24.
This is less than Mar-24 when it was ₹94.79 Crs.

The profit is oscillating.
The profit of SMS Lifesciences is ₹21.72 Crs for TTM, ₹9.09 Crs for Mar 2024 and ₹11.46 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
SMS Lifesciences latest dividend payout ratio is 4.99% and 3yr average dividend payout ratio is 3.58%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech